Relmada Therapeutics RLMD
NASDAQ RLMD
$3.21 -0.15 (-4.46%)
At close: Oct 21, 2026 · 4:00 PM EDT

Relmada Therapeutics (RLMD) Other Operating Expenses (2012 - 2022)

Updated

Relmada Therapeutics (RLMD) recorded Other Operating Expenses of $6.35 million in FY2022.

Analysis

Relmada Therapeutics (RLMD) Other Operating Expenses (2012 - 2022) Analysis & Trends

  • The FY2022 figure is the lowest annual Other Operating Expenses since FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Relmada Therapeutics 361.29 Mn -197.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 6.35 Mn
Feb 28, 2013 723.00
Nov 30, 2012 309.00
Aug 31, 2012 1,048.00
API Access

Relmada Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=RLMD&period=max&api_key=YOUR_API_KEY